DLA Piper advised Agilent Technologies on the deal. Agilent Technologies, Inc. (Agilent), a global leader in life sciences, diagnostics and applied chemical markets, announced its proposed...
You must be a Standard 1 Year member to access this content.
Freshfields advised Agilent on its sale of Resolution Bioscience. Agilent Technologies, Inc. (NYSE: A) and Exact Sciences Corp. (Nasdaq: EXAS) have formally agreed to the sale...
You must be a Standard 1 Year member to access this content.
Weil represented Synthego, and Bunsow De Mory represented Agilent. Synthego secured a major victory when the Patent Trial and Appeal Board (PTAB) decisively invalidated two Agilent...
You must be a Standard 1 Year member to access this content.
Freshfields advised Agilent (NYSE: A) on its acquisition of Resolution Bioscience. The combination brings together Resolution Bioscience’s noninvasive liquid biopsy platform that improves cancer diagnostics with...
You must be a Standard 1 Year member to access this content.
